Serum Pharmacochemistry and Metabolomics Reveal the Mechanism of Hedan Tablets Combined With Simvastatin in Hyperlipidemia Treatment
Biomedical Chromatography · 2026
DOI: 10.1002/bmc.70630 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Shuo Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Shenyang Pharmaceutical University, Shenyang, China. Hauptthemen laut MEDLINE: Simvastatin, Hyperlipidemias, Drugs, Chinese Herbal, Metabolome. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Department of Education of Liaoning Province.
Abstract (Originalsprache)
Simvastatin (ST) is commonly used to treat hyperlipidemia (HLP), but it has serious side effects, such as myopathy and hepatotoxicity. Clinically, statins are often combined with Hedan tablets (HDT) to treat HLP, but the composition and mechanism of their pharmacological effects are still unclear. Therefore, the purpose of this study was to systematically explore the pharmacodynamic material basis and mechanism of HDT combined with ST in the treatment of HLP. Efficacy was assessed through serum lipid profiles and oxidative stress markers. The components entering the blood were identified by LC–MS. Metabolomic analyses were conducted using LC–MS and 1 H‐NMR techniques. Both single administration and combined administration have the effects of regulating blood lipids and oxidative stress, and the combination group showed significantly greater regulatory effects on TC, HDL‐C, and GSH‐Px than the simvastatin monotherapy group ( p < 0.05). Twenty components were successfully identified in blood. Metabolomics revealed 61 significantly altered metabolites in the combination group, mapped to nine key metabolic pathways including glycerophospholipid metabolism and citrate cycle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Shenyang Pharmaceutical University, Shenyang, China.
- Zhongshan College of Dalian Medical University, Dalian, China.
- School of Public Health, Shenyang Medical College, Shenyang, China.
ORCID-Profile: Min Zhao
Förderung
- Department of Education of Liaoning Province
Zitieren
APA
Liu, S., Zhang, Y., Dun, X., Zhang, J., Zhao, C., Huang, Y., & Zhao, M. (2026). Serum Pharmacochemistry and Metabolomics Reveal the Mechanism of Hedan Tablets Combined With Simvastatin in Hyperlipidemia Treatment. Biomedical Chromatography. https://doi.org/10.1002/bmc.70630
Vancouver
Liu S, Zhang Y, Dun X, Zhang J, Zhao C, Huang Y, et al. Serum Pharmacochemistry and Metabolomics Reveal the Mechanism of Hedan Tablets Combined With Simvastatin in Hyperlipidemia Treatment. Biomedical Chromatography. 2026. doi:10.1002/bmc.70630
BibTeX
@article{Liu2026,
author = {Liu, Shuo and Zhang, Yumeng and Dun, Xiaoxu and Zhang, Jingxuan and Zhao, Chunjie and Huang, Yihe and Zhao, Min},
title = {Serum Pharmacochemistry and Metabolomics Reveal the Mechanism of Hedan Tablets Combined With Simvastatin in Hyperlipidemia Treatment},
journal = {Biomedical Chromatography},
year = {2026},
doi = {10.1002/bmc.70630}
}
EUVIMED